No phaseCompleted
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA)
- Sponsor
- Mayo Clinic (Academic or other)
- Enrollment
- 2,204 enrolled
- Conditions
- Atrial Fibrillation; Arrhythmia
- Interventions
- Left atrial ablation; Rate or Rhythm Control Therapy
- Ages
- adults, older adults
- Registry
- NCT00911508
Full record on ClinicalTrials.gov
From the registry
The (Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial) CABANA Trial has the overall goal of establishing the appropriate roles for medical and ablative intervention for atrial fibrillation (AF). The CABANA Trial is designed to test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating atrial fibrillation (AF) will be superior to current state-of-the-art therapy with either rate control or rhythm control drugs for decreasing the incidence of the composite endpoint of total mortality, disabling stroke, serious bleeding, or cardiac arrest in patients with untreated or incompletely treated AF.
Primary outcomes
- Number of Participants With Composite of Total Mortality, Disabling Stroke, Serious Bleeding, or Cardiac Arrest in Patients Warranting Therapy for AF.
History
Last registry update
Results first posted
Primary completion
Started
Registered